65 I B, drugs, pharmaceuticals,&hematology related products, FSS contract award
Active Awarded Last action
- Contract number
- 36F79719D0246
- Awardee
-
Merz Pharmaceuticals, LLC UEI UMD1NK9KU143
- Awarding agency
-
Veterans Integrated Service Network 12
Veterans Health Administration, Department of Veterans Affairs
- Task orders
- 4
Award facts
- Opportunity
-
- 651B Solicitation number
- 6505--Karyopharm Therapeutics Inc. 651B - 36F79720D0089 effective 4/1/2020 - 3/31/2025 Special Notice · Posted Feb 25, 2020
- Merz Pharmaceuticals, LLC 09-15-2019-09-14-2024 Award Notice · Posted Sep 10, 2019
- Last date to order 89% complete
- IDV ceiling
- $95,726,580.00
- Award type
- Multiple award
- Who can order
- All agencies
- Contracting staff
- NAICS code
- 325412 Pharmaceutical Preparation Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Fixed Price with Economic Price Adjustment
Award details come from SAM.gov/FPDS.
About this IDV
Merz Pharmaceuticals, LLC, a foreign-owned pharmaceutical company, was awarded a multiple-award Federal Supply Schedule contract under General Services Administration schedule 61-IB (Pharmaceuticals and Drugs) on September 15, 2019, with a ceiling value of $95.7 million and ultimate completion date of September 14, 2027. The contract was funded by the Veterans Integrated Service Network 12 (VISN 12), a civilian agency within the Department of Veterans Affairs, with no small business set-aside utilized. The contract encompasses the supply of pharmaceutical products with performance conducted in Raleigh, North Carolina, operating under firm fixed-price delivery order structures. Merz Pharmaceuticals leverages this Federal Supply Schedule vehicle to provide pre-negotiated pharmaceutical products to federal healthcare institutions, particularly supporting the Department of Veterans Affairs' mission to deliver medication supplies to veteran populations across the VISN 12 network.
The contract's scope includes multiple therapeutic pharmaceutical products, with delivery orders executed for Levodopa formulations—a medication used in treating Parkinson's disease and related neurological conditions—valued at approximately $1.5 million across three documented task orders with completion dates ranging from September 2025 through March 2026. Additionally, Merz Pharmaceuticals holds a complementary single-award Blanket Purchase Agreement under the same GSA pharmaceutical schedule, awarded by the National Acquisition Center on March 13, 2025, with a $12.1 million ceiling through March 12, 2027, providing streamlined federal procurement access to Ampyra (dalfampridine) for multiple sclerosis and Inbrijia (tirzepatide) for weight management and glycemic control. Together, these vehicles enable efficient, cost-effective acquisition of critical pharmaceutical supplies supporting federal healthcare delivery while maintaining pre-negotiated pricing and standardized procurement terms across the Veterans Health Administration and other federal agencies.
Task orders
| Task order | Ordering agency | Obligated | Awarded |
|---|---|---|---|
| Levodopa | Veterans Integrated Service Network 15 (VHA) | $236,612 | |
| Levodopa | Veterans Integrated Service Network 15 (VHA) | $709,836 | |
| Levodopa 42MG inhl cap 60 | Veterans Integrated Service Network 15 (VHA) | $143,561 | |
| Levodopa NDC 10144-0342-60 | Veterans Integrated Service Network 15 (VHA) | $653,990 |
IDV awards
| IDV | Agency | Ceiling | Awarded |
|---|---|---|---|
| 36E79725A0009 | National Acquisition Center (VA) | $12,057,300 |
Transactions
| Action | Obligated | Date |
|---|---|---|
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Add Subcontract Plan | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Add Subcontract Plan | $0 | |
| Other Administrative Action | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Supplemental Agreement for work within scope | $0 | |
| Original award | $0 |
Show all 33
Quick answers
Who was awarded contract 36F79719D0246?
36F79719D0246 was awarded to Merz Pharmaceuticals, LLC by Veterans Integrated Service Network 12 (Veterans Health Administration) on September 15, 2019.
How much is contract 36F79719D0246 worth?
36F79719D0246's own ceiling is $95,726,580.
How many orders have been placed under contract 36F79719D0246?
4 orders have been placed under 36F79719D0246, the latest on September 8, 2026.
Who can order from contract 36F79719D0246?
36F79719D0246 is a multiple award federal supply schedule. All agencies can place orders on it.
Is contract 36F79719D0246 part of a contract vehicle?
Yes. 36F79719D0246 is part of Pharmaceuticals and Drugs (FSS-61-IB).
Was contract 36F79719D0246 competed?
The extent of competition for 36F79719D0246 was full and open competition.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV